Vaccine shows promise against aggressive breast cancer (Links to an external site)

A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors. Conducted at Washington University School of Medicine in St. Louis with a therapy designed by WashU Medicine researchers, the trial is the first to report results for this type of vaccine — known as a neoantigen DNA vaccine — for breast cancer patients.

Zayed Receives WashU Gap Fund Award (Links to an external site)

Photo of Dr. Zayed standing outside of the medical campus

Vascular surgeon Mohamed Zayed, MD, PhD, MBA, received a WashU Gap Fund Award to perform translational researcḥ on technology that emerged in the CardioVascular Research Innovation in Surgery and Engineering (CVISE) Center.